In a clinical trial, what is the purpose of having a control group?

• A. To have a baseline for comparison with the treatment group
• B. To evaluate qualitative outcomes
• C. To ensure random subject selection
• D. To account for participant bias

Answer: (A)

Having a control group in a clinical trial serves the fundamental purpose of establishing a baseline for comparison with the treatment group. This allows researchers to determine the effectiveness of the intervention being tested. By comparing the outcomes in the control group, which does not receive the treatment or receives a standard treatment, to those in the treatment group, any observed effects can be more clearly attributed to the intervention itself rather than to other external factors.

The control group provides a standard against which the results can be measured; for example, if the treatment group shows improvement while the control group does not, it is more likely that the intervention is responsible for the observed effects. This increases the validity of the trial and helps to ensure that the conclusions drawn from the results are scientifically sound.

The other options, while relevant to various aspects of clinical trials, do not specifically address the primary function of a control group. Evaluating qualitative outcomes pertains to how different types of data are analyzed, ensuring random subject selection relates to minimizing bias in the trial, and accounting for participant bias focuses on individual perceptions and behaviors that may affect the outcomes. None of these alternatives directly capture the essential role of the control group in facilitating robust comparisons to assess treatment efficacy.